Insights On Drug Development
-
Formulation & Delivery Of Spray Dried Biologics For Nasal Dosage Forms
4/27/2026
Spray drying enables stable, scalable dryâpowder nasal biologics, improving shelf life, particle control, and targeted delivery for peptides, proteins, vaccines, and oligonucleotides.
-
Unlocking The Next Wave Of Cancer Vaccines
4/21/2026
Discover how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines.
-
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era
4/21/2026
Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
IP Considerations In Drug Development For Biotech Companies
4/20/2026
Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.
-
Lipids Center Of Excellence
4/14/2026
Examine high-quality, GMP-compliant lipids that are engineered for pharmaceutical and gene therapy applications, with options ranging from standard formulations to custom blends for improved stability.
-
How Proactive Regulatory Planning Supports Improved Drug Formulation And Manufacture
4/13/2026
Integrating regulatory strategy with R&D planning early in drug development helps to minimize formulation risks and align manufacturing with compliance while preventing costly delays.
-
Beyond Particle Counting: Why Modern Biologics Need Particle Forensics
4/8/2026
High particle counts don’t always mean high risk. Identifying particle type and origin—not just quantity—avoids false alarms, protects timelines, and turns data into action.
-
Flexibility In Drug Development: From Tactical Response To Strategic Imperative
4/6/2026
Build flexibility into your drug development strategy to navigate change effectively, maintain momentum, and drive successful outcomes across every stage of the lifecycle.
-
Early-Phase Injectable Formulation Development
4/6/2026
Discover how expert-driven strategies and data-centric tools can help you overcome formulation challenges and accelerate the development of stable, high-performance injectable therapeutics.
-
Systematic Strategy To Reduce The Cost Of Goods Sold
3/26/2026
Learn key ways to cut biologics manufacturing costs through smarter process design, material choices, and supply resilience — driving more efficient, reliable, and commercially sustainable production.